![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Changzhou Yinsheng Pharmaceutical Co., Ltd. Changzhou Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Tranexamic acid, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2009-109 - Rev 00
This Chemical Type CEP, issued on October 07, 2011, remains in force until July 08, 2016, ensuring its reliability within the pharmaceutical industry.
Substance Number 875 associated with this CEP further emphasizes